GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Grifols SA (XMAD:GRF) » Definitions » Other Gross PPE

Grifols (XMAD:GRF) Other Gross PPE : €1,216 Mil (As of Dec. 2023)


View and export this data going back to 2006. Start your Free Trial

What is Grifols Other Gross PPE?

Grifols's Other Gross PPE for the quarter that ended in Dec. 2023 was €1,216 Mil.

Grifols's quarterly Other Gross PPE increased from Jun. 2023 (€3,226 Mil) to Sep. 2023 (€3,279 Mil) but then declined from Sep. 2023 (€3,279 Mil) to Dec. 2023 (€1,216 Mil).

Grifols's annual Other Gross PPE increased from Dec. 2021 (€942 Mil) to Dec. 2022 (€1,115 Mil) and increased from Dec. 2022 (€1,115 Mil) to Dec. 2023 (€1,216 Mil).


Grifols Other Gross PPE Historical Data

The historical data trend for Grifols's Other Gross PPE can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Grifols Other Gross PPE Chart

Grifols Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Gross PPE
Get a 7-Day Free Trial Premium Member Only Premium Member Only 685.41 665.00 941.95 1,114.65 1,216.06

Grifols Quarterly Data
Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Dec21 Jun22 Sep22 Dec22 Jun23 Sep23 Dec23
Other Gross PPE Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 1,114.65 3,225.68 3,278.65 1,216.06

Grifols Other Gross PPE Calculation

GuruFocus lists Land And Improvements, Buildings And Improvements, Machinery, Furniture, Equipment, Construction In Progress and Other Gross PPE under the "Gross Property, Plant and Equipment" section.


Grifols (XMAD:GRF) Business Description

Address
Avinguda de la Generalitat, 152-158, Parc de Negocis Can Sant Joan, Sant Cugat del Valles, Barcelona, ESP, 08174
As a vertically integrated plasma derivative producer, Spain-based Grifols collects plasma and then manufactures and sells plasma-derived products globally. By acquiring Talecris in 2011, Grifols dramatically expanded its plasma-derived product portfolio, and the firm's biopharma business contributed 83% of sales in 2022. Grifols also has smaller segments including diagnostics and biosupplies. Diagnostics is roughly 10% of revenue following the Biotest acquisition.